PharmaShots

Eris Lifesciences Acquires Novartis’ Zomelis (vildagliptin) in India for $13M

December 4, 2019December 4, 2019Tuba Khan

Shots: Eris Lifesciences acquired Novartis’ novel therapy Zomelis for $13M (~INR 93 crore) and will initiate the commercialization of product from Dec 10, [Read More...]

Octavus Consulting Collaborates with IBCI for Delivering of Professional Educational Programs in India from 2020

November 28, 2019November 29, 2019Shiwani Sharma

Shots: The IBCI educational programs will focus on providing perspectives on Business & Competitive Intelligence role in every industry for professionals from all [Read More...]

Lupin Launches Smart Device for Metered-Dose Inhalers to Support Treatment of Respiratory Diseases in India

November 22, 2019November 22, 2019Tuba Khan

Shots: Lupin in collaboration with Aptar Pharma launch ADHERO, a smart device designed to help patients with chronic respiratory diseases by tracking MDI [Read More...]

Johnson & Johnson Vision Launches TECNIS Eyhance Monofocal Intraocular Lens for Post Cataract Surgery Patients in India

October 31, 2019October 31, 2019Tuba Khan

Shots: J&J Vision launches TECNIS Eyhance monofocal IOL to provide the advance solution for patients who have undergone cataract removal surgery The launch [Read More...]

Cipla to Acquire Venus Remedies’ Elores to Strengthen its Critical Care Footprints in India

October 18, 2019October 18, 2019Shiwani Sharma

Shots: Cipla acquires Venus’ anti-infective products, Elores to robust its presence in Indian critical care space as a part of its agenda to [Read More...]

Zentiva to Acquire Sanofi’s Ankleshwar Manufacturing Facility in India

September 12, 2019October 3, 2019Tuba Khan

Shots: Sanofi signs a business transfer agreement with Zentiva to sell its manufacturing facility in Ankleshwar, India. In H1’19, Zentiva enhanced its network [Read More...]

Dr. Reddy's Laboratories Launches Versavo (biosimilar, bevacizumab) for Multiple Cancers in India

Dr. Reddy’s Laboratories Launches Versavo (biosimilar, bevacizumab) for Multiple Cancer Indications in India

August 20, 2019August 20, 2019Tuba Khan

Shots: Dr. Reddy’s has launched Versavo (bevacizumab), a biosimilar of Roche’s Avastin in 100mg and 400mg single use vials for the treatment of [Read More...]

Glenmark’s Combination Therapy of Remogliflozin Etabonate + Metformin Hydrochloride Receive Approval for Type 2 Diabetes in India

August 19, 2019August 19, 2019Tuba Khan

Shots: Glenmark has received the regulatory approval to commercialize the combination therapy of remogliflozin etabonate (100mg) + metformin hydrochloride (500/1000mg) as an adjunct [Read More...]

Torrent Signs a Non-Exclusive License Agreement with Glenmark to Co-Commercialize Remogliflozin Etabonate for Type 2 Diabetes in India

July 11, 2019July 11, 2019Tuba Khan

Shots: Glenmark to receive up front, license fee and royalties on sales and is responsible to manufacture and supply Remogliflozin. Torrent to get [Read More...]

Dr. Reddy Launched Hervycta (biosimilar Trastuzumab) in India

July 27, 2018June 18, 2019Shiwani Sharma

Shots: Hervycta (biosimilar Trastuzumab) indicated for the treatment of HER2-positive cancers (early breast cancer, metastatic breast cancer and metastatic gastric cancer) Marketed as [Read More...]